Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Conserved Binding Sites01:49

Conserved Binding Sites

4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
GPCR Desensitization01:12

GPCR Desensitization

5.8K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.8K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neonatal expression of human FMRP isoform corrects cortical deficits and improves behavior in a mouse model of fragile X syndrome.

Molecular therapy. Nucleic acids·2026
Same author

Neuronal toll-like receptor-4 regulation of matrix metalloproteinase-9 activity mediates dentate circuit dysfunction after traumatic brain injury.

Journal of neuroinflammation·2026
Same author

Covalent Targeting of Histidine Residues: A Ligand-First Approach.

Journal of medicinal chemistry·2026
Same author

Neuronal Toll-like Receptor-4 regulation of Matrix Metalloproteinase-9 Activity Mediates Dentate Circuit Dysfunction after Traumatic Brain Injury.

bioRxiv : the preprint server for biology·2026
Same author

Astrocytic GABA controls fidelity of temporal cortical processing in Fragile X Syndrome.

Neurobiology of disease·2025
Same author

Pre-clinical evaluation of a potent and effective Pin1-degrading agent in pancreatic cancer.

Molecular therapy. Oncology·2025

Related Experiment Video

Updated: Jun 5, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.3K

Constrained β-Hairpins Targeting the EphA4 Ligand Binding Domain.

Anne Marie Prentiss1, Carlo Baggio1, James Pagett1

  • 1Division of Biomedical Sciences, School of Medicine, University of California Riverside, 900 University Avenue, Riverside, California 92521, United States.

Journal of Medicinal Chemistry
|December 10, 2024
PubMed
Summary

Researchers developed novel EphA4-LBD binding agents, specifically a β-hairpin mimetic, to overcome limitations in targeting EphA4 for cancer and neurodegenerative diseases. This breakthrough offers new therapeutic development strategies.

More Related Videos

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.7K
Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
08:21

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Published on: June 28, 2019

6.8K

Related Experiment Videos

Last Updated: Jun 5, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.3K
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.7K
Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
08:21

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Published on: June 28, 2019

6.8K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Neuroscience

Background:

  • EphA4 receptor tyrosine kinase is linked to gastric cancer, pancreatic cancer, ALS, and Alzheimer's disease.
  • Developing EphA4 as a drug target is hindered by a lack of effective pharmacological inhibitors.
  • Previous research utilized phage display cyclic peptides to inhibit EphA4.

Purpose of the Study:

  • To design and develop novel EphA4-targeting agents.
  • To create high-affinity inhibitors for the EphA4 ligand-binding domain (LBD).
  • To explore a new strategy for designing constrained β-hairpin peptides.

Main Methods:

  • Design of a β-hairpin mimetic based on prior cyclic peptide inhibitor studies.
  • Targeting the ligand-binding domain (LBD) of EphA4.
  • Affinity assessment of the designed mimetic for EphA4-LBD.

Main Results:

  • Successful design of a potent EphA4-LBD binding agent.
  • The developed β-hairpin mimetic demonstrated high affinity for EphA4-LBD.
  • The study established a novel strategy for constrained β-hairpin peptide design.

Conclusions:

  • The designed EphA4-LBD binding agents show significant promise for therapeutic development.
  • These findings advance the validation of EphA4 as a drug target for various pathologies.
  • A new method for creating constrained β-hairpin peptides has been introduced.